Swiss Society
of Cannabis in Medicine

Professional Informations and Therapy Recommendations

Evidence- and experience-based therapy recommendations should support health professionals in practice.


Patient Informations

In cooperation with patient organizations we elaborate professional informations for patients and relatives.


We provide information about the legal and regulatory situation concerning medicinal cannabis and cannabinoids, particularly following the revision of the Swiss Narcotics Act in 2022, as well as new approvals of related preparations.


We participate in various conferences on the topic of cannabis in medicine, sometimes with a booth and sometimes as (co-)organizers.

Here is the overview


We are active in the education of health professionals, patients and other interested people, aiming to most efficiently and safely use cannabis and cannabinoids in medicine.

Scientific Journals

«Medical Cannabis and Cannabinoids» is the scientific journal of SGCM-SSCM. It is published by Karger in Basel allowing open access. The peer-reviewed journal offers an international forum for the presentation and discussion of research results covering the rapidly developing use of cannabis and cannabinoids in medicine.


We support the clinical and basic research for the medicalization of cannabis and cannabinoids.


A data base should allow us to evaluate and validate the different treatments, indications and therapy experiences. Consequently, this is the basis for the elaboration of therapy recommendations and guidelines.